Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab. (Q38109282)
Jump to navigation
Jump to search
scientific article published on 22 May 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab. |
scientific article published on 22 May 2013 |
Statements
Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab (English)
Benjamin Bakall